During the past decade, Wake Forest Baptist Health - Infectious Diseases conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Wake Forest Baptist Health - Infectious Diseases" are "COVID-19" (3 trials) and "Syphilis" (1 trials). Many other conditions were trialed in "Wake Forest Baptist Health - Infectious Diseases" in a lesser frequency.

Most popular intervention types in "Wake Forest Baptist Health - Infectious Diseases" are "Drug" (4 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Remdesivir" (3 trials), "Benzathine Penicillin" (1 trials), "Danicopan" (1 trials) and "Lenzilumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wake Forest Baptist Health - Infectious Diseases" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Wake Forest Baptist Health - Infectious Diseases". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Wake Forest Baptist Health - Infectious Diseases, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wake Forest Baptist Health - Infectious Diseases, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".